NCT03269682View on ClinicalTrials.gov

Prevalence of Contrast Enhancement of the Oculomotor Nerve on 3D PD T1 MRI Sequence in Patients With Ophthalmoplegia

CompletedOBSERVATIONAL

Enrollment

134

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

April 16, 2021

Study Completion Date

April 16, 2021

Conditions

Ophthalmoplegia

Interventions

DEVICE

3D PD T1 MRI sequence

After MRI has been performed (about 5 minutes of additional time compared to the usual sequences), a double reading of the MRI will be performed by two radiologists (1 experienced and 1 junior).

Trial Locations (1)

75019

Fondation Ophtalmologique A. de Rothschild, Paris

All Listed Sponsors

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03269682 - Prevalence of Contrast Enhancement of the Oculomotor Nerve on 3D PD T1 MRI Sequence in Patients With Ophthalmoplegia | Biotech Hunter | Biotech Hunter